Stock Analysis of ProKidney Corp. (PROK) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code PROK
Close 3.48
Change -0.720 / 17.14 %
Volume 565468
Vol Change -109985.00 / 16.28 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthMild Bearish
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Poor Stability Stock


Fundamental View of ProKidney Corp.
PE (TTM)

-609.00

Very Poor
Price / Book

126.73

Very Poor
Price / Sales

11959.75

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

222452 K

Enterprise Value

162606 K

ROA (TTM)

-19.70

Very Poor
ROE (TTM)

0

Poor
Net Margin (TTM)

-1963.82

Very Poor
Revenue

%

0
Net Profit

66.44 %

-36254.00 K
Debt to Equity

-0.0007

Very Poor
Altman Z Score

1.49

Not Good
Quick Ratio

0

Poor
Cash Ratio

14.50

Excellent


Highs/Lows of ProKidney Corp.
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week3.37 3.26 % 0.513 % 4.34993.2729-May-2431-May-24
Two Week4.055 14.18 % 0.486 % 4.443.2720-May-2431-May-24
One Month2.065 68.52 % 4.80 % 4.442.0320-May-2403-May-24
Three Month1.63 113.50 % 3.56 % 4.441.3420-May-2414-Mar-24
Six Months1.68 107.14 % 15.54 % 4.441.1820-May-2413-Feb-24
One year12.14 71.33 % 26.26 % 13.511.1211-Aug-2317-Nov-23


Technical View of ProKidney Corp.
RSI

54.30

Neutral
MACD

0.392

Whipsaw
ADX

44.83

Mild Bullish
Super Trend

2.81

Mild Bullish
Williams %R

-60.98

Strong Bearish
CCI

36.40

Neutral


EMA 5

3.75

Strong Bearish
EMA 15

3.53

Bearish
EMA 50

2.76

Bullish
EMA 100

2.58

Strong Bullish
SMA 100

1.98

Strong Bullish
SMA 200

2.88

Strong Bullish
SMA 5 / 20

3.74 / 3.35

Bullish
SMA 15 / 50

3.68 / 2.50

Strong Bullish
SMA 50 / 200

2.50 / 2.88

Mild Bearish




Charts of ProKidney Corp.


Returns of ProKidney Corp. with Peers
Period / StockPROKELYMMACKIPHA
1 Week3.26%4.05%0.066%-5.56%
1 Mth68.52%8.74%3.07%18.61%
3 Mth113.50%182.42%2.93%4.58%
6mth107.14%201.17%18.02%14.17%
1 Year-71.33%164.04%18.02%-6.80%
2 Year-101.31%196.09%3.01%
5 Years--152.17%-
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of ProKidney Corp. with Peers
Ratio / StockPROKELYMMACKIPHA
PE-609.00-14.501.08-2.72
P/B126.731.903.654.09
ROA-19.70-12.72311.38-41.33
ROE0-13.13337.01-150.51
Debt To Equity-0.00070.003100.762
Revenue0
% 		0
% 		0
100.00 % 		51901.00 K
4.56 %
Net Income-36254.00 K
66.44 % 		-39240.00 K
13.27 % 		-1433.00 K
7.19 % 		-7570.00 K
86.97 %


Technicals of ProKidney Corp. with Peers
Technical / StockPROKELYMMACKIPHA-
ADX44.8345.1368.8020.05
CMF0.098-0.143-0.4840.249
MFI73.9332.3078.1144.95
RSI54.3055.8678.9752.66
MACD Abv SignalFalseFalseTrueFalse
Price Above 50 MATrueTrueTrueTrue-
Price Above 200 MATrueTrueTrueTrue-


About : ProKidney Corp.

Address : 2000 Frontis Plaza Blvd., Winston-Salem, NC, United States, 27103
Tel : 336 999 7028
URL : https://www.prokidney.com
Code : PROK, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 12_Jul_2022
Employee Count : 163

ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases in the United States. The company's lead product is Renal Autologous Cell Therapy (REACT), an autologous homologous cell admixture, which has completed Phase I clinical trial for REACT in patients with congenital anomalies of the Kidney and Urinary Tract (CAKUT), as well as in Phase III and Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease. ProKidney Corp. founded in 2015 and is headquartered in Winston-Salem, North Carolina.


Note : All Data Generated at the End of Trading Hours (EOD Data)